BioXCell抗體三月限-時(shí)優(yōu)惠！體內(nèi)研究抗體金標(biāo)準(zhǔn)~

是否經(jīng)過結(jié)合驗(yàn)證(immunoblot，FC或ELISA驗(yàn)證)

No

Yes

是否經(jīng)過鼠科病原體檢測(cè)(采用超靈敏實(shí)時(shí)熒光定量PCR檢測(cè))

No

Yes

是否經(jīng)驗(yàn)證蛋白聚集篩選(由動(dòng)態(tài)光散射確定)

No

Yes

內(nèi)毒素含量 (LAL測(cè)定)

＜2EU/mg

＜1EU/mg

純度測(cè)定(SDS-PAGE)

>95%

>95%

是否不含防腐劑、穩(wěn)定劑和載體蛋白

Yes

Yes

是否適用于體內(nèi)研究

Yes

Yes

產(chǎn)品貨號(hào)

BE-開頭

BP-開頭

PD-1 (CD279)

in vivo blocking of PD-1/PD-L signaling, WB

BE0146

BP0146

in vivo blocking of PD-1/PD-L signaling, in vitro PD-1 neutralization

BE0033-2

BP0033-2

PD-L1(B7-H1)

in vivo PD-L1 blockade, IF, IHC-F, FC, WB

BE0101

BP0101

CTLA-4 (CD152)

in vivo CTLA-4 neutralization, WB

BE0164

BP0164

in vivo and in vitro CTLA-4 neutralization

BE0131

BP0131

CD4

in vivo CD4+ T cell depletion, FC

BE0003-1

BP0003-1

Ly6G

in vivo neutrophil depletion, in vivo MDSC depletion, IF, IHC-P, IHC-F, FC

BE0075-1

BP0075-1

in vivo depletion of Gr-1+ myeloid cells, FC

BE0075

BP0075

CD8α

in vivo CD8+T cell depletion

BE0061

BE0117

BP0061

BP0117

in vivo CD8+ T cell depletion, IF, FC

BE0004-1

BP0004-1

OX40 (CD134)

in vivo and in vitro OX40 activation

BE0031

CSF1R (CD115)

in vivo macrophage/monocyte depletion, in vitro CSF-R1 neutralization, FC

BE0213

CD40

in vivoCD40 activation, in vitro B cell stimulation, in vitro DC stimulation

BE0016-2

BP0016-2

IFNγ

in vivo and in vitro IFNγ neutralization, ELISPOT, FC

BE0055

BP0055

GITR

in vivo GITR stimulation

BE0063

CD154 (CD40L)

in vivo and in vitro blocking of CD40/CD40L signaling

BE0017-1

BP0017-1

NK1.1

in vivo NK cell depletion, FC

BE0036

BP0036

TGF-β

in vivo TGFβ neutralization, in vitro TGFβ neutralization

BE0057

BP0057

Rat IgG2a Isotype control, FC

BE0089

BP0089

Rat IgG2b Isotype control

BE0090

BP0090

Mouse IgG1 Isotype control

BE0083

BP0083

Rat IgG1 Isotype control

BE0088

BP0088

Mouse IgG2a Isotype control

BE0085

BP0085

Mouse IgG2b Isotype control

BE0086

BP0086

Polyclonal Armenian Hamster IgG

BE0091

BP0091